Europe — EMA

Paclitaxin Teva Pharma (Paclitaxel)

Paclitaxel, the active ingredient in Paclitaxin Teva Pharma, is a taxane presented as a sterile injectable solution for intravenous use.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxin Teva Pharma, is a taxane presented as a sterile injectable solution for intravenous use. It is employed in the treatment of various malignant neoplasms and is administered under the supervision of oncology specialists.

GNH USA supplies Paclitaxin Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Paclitaxel used for?

Paclitaxel is a chemotherapeutic agent that interferes with cell‑division pathways in solid tumours. It is indicated for: - Breast cancer: improves the overall response rate and adds to progression‑free survival of the patient as an adjuvant treatment. - Ovarian cancer: enhances the efficacy of platinum‑based regimens by stabil of micro‑t . - Non‑small cell lung ... - ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - .... ... ... ... ... .... - .... ... ...

What are the side effects of Paclitaxel?

The ... ... … ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →